HYPOVITAMINOSIS D AND ORGAN DAMAGE IN PATIENTS WITH HYPERTENSION: EFFECTS OF SUPPLEMENTATION WITH CHOLECALCIFEROL

Trial Profile

HYPOVITAMINOSIS D AND ORGAN DAMAGE IN PATIENTS WITH HYPERTENSION: EFFECTS OF SUPPLEMENTATION WITH CHOLECALCIFEROL

Recruiting
Phase of Trial: Phase III

Latest Information Update: 17 Apr 2017

At a glance

  • Drugs Colecalciferol (Primary)
  • Indications Essential hypertension; Vitamin D deficiency
  • Focus Therapeutic Use
  • Acronyms HYPODD
  • Most Recent Events

    • 06 Nov 2015 New trial record
    • 14 Mar 2015 Planned number of patients changed to 240.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top